Children's Hospital Los Angeles
The goal of this clinical trial is to improve the successful healthcare transition from pediatric to adult-focused care for childhood cancer survivors. The main questions it aims to answer are * Receipt of the intervention (vs. standard of care control) will increase the proportion of CCS achieving transition success to adult-focused survivorship care from 50% to 70%. * Receipt of the intervention (vs. standard of care control) will significantly reduce patients' unmet HRSN. * Intervention effectiveness will be moderated by sociodemographic factors (gender, race/ethnicity, insurance status), medical risk for late effects, HRSN burden, and patient-reported outcomes (quality of life, self-efficacy). Researchers will compare those that receive intervention versus standard of care. Patients are randomized to either an intervention group, receiving structured PN-led sessions and tailored support for care transitions, or a control group receiving standard follow-up by a nurse case manager. High-HRSN patients in the intervention arm get monthly check-ins and coordinated handoffs to adult care providers for continuity.
Inclusion Criteria: * diagnosed between the ages of 0-19 years with cancer or with any condition treated with cancer-like therapy. * currently in follow up at survivorship clinic or had a survivorship launch visit during the 12 months prior to study activation. * current age 20-29 (\>95% of patients will be age 20-21) * meet LIFE Clinic transition readiness criteria, as clinically applied: * at least 5 years off treatment * medically stable * demonstrate a workable understanding of transition * have an identified primary care provider * able to speak and read English or Spanish * can provide…
Follow Up
Standard of Care
Arctuva estimate
Verify or correct the compensation shown for this listing.